Company Profiles

driven by the PitchBook Platform

Elusys Therapeutics

Description

Developer of antibody therapeutics designed to treat infectious diseases. The company's antibody therapeutics treat anthrax exposure following a natural or intentional release of anthrax spores, enabling patients to prevent inhaled anthrax.

1998

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$55.9M

Total Amount Raised

12

Investors

Description

Developer of antibody therapeutics designed to treat infectious diseases. The company's antibody therapeutics treat anthrax exposure following a natural or intentional release of anthrax spores, enabling patients to prevent inhaled anthrax.

Website:

www.elusys.com

Formerly Known As

E-site Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

25 Riverside Drive Unit One Pine Brook, NJ 07058United States +1 (973) 808-0222
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Elusys Therapeutics's full profile, request a free trial.

Elusys Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Elusys Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Elusys Therapeutics Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ClearBridgeAsset ManagerMinority000 0000000 0000
Crescendo Ventures ManagementVenture CapitalMinority000 0000000 0000
Eagle VenturesVenture CapitalMinority000 0000000 0000
EW Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
InvescoFund of FundsMinority000 0000000 0000
ClearBridge Asset Manager
Crescendo Ventures Management Venture Capital
Eagle Ventures Venture Capital
EW Healthcare Partners Growth/Expansion
Invesco Fund of Funds

Elusys Therapeutics Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Elizabeth Posillico Ph.DPresident, Chief Executive Officer and Board Member
Lawrence GyenesChief Financial Officer
Debra DuffySenior Director, Human Resources & Administration
Jeremy MiddletonVice President, Corporate Development
James PorterVice President, Development and Manufacturing
Elizabeth Posillico Ph.D President, Chief Executive Officer and Board Member
Lawrence Gyenes Chief Financial Officer
Debra Duffy Senior Director, Human Resources & Administration
Jeremy Middleton Vice President, Corporate Development
James Porter Vice President, Development and Manufacturing

Elusys Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
Frank Young Ph.DEW Healthcare PartnersAdjunct Partner000 0000
Jeffrey Wolf JDSelfBoard Member & Founder000 0000
Johnston EvansInvescoBoard Member000 0000
Ronald EastmanEW Healthcare PartnersManaging Director000 0000
Frank Young Ph.D Adjunct Partner EW Healthcare Partners
Jeffrey Wolf JD Board Member & Founder Self
Johnston Evans Board Member Invesco
Ronald Eastman Managing Director EW Healthcare Partners
Request full access to PitchBook